Log in

ASX:VLS - Vita Life Sciences Stock Price, Forecast & News

Today's Range N/A
50-Day Range
MA: A$0.71
52-Week Range N/A
Volume2,815 shs
Average VolumeN/A
Market Capitalization$38.44 million
P/E Ratio15.80
Dividend Yield6.36%
Vita Life Sciences Limited, a pharmaceutical and healthcare company, engages in formulation, packaging, sale, and distribution of vitamins and supplements. It offers a range of supplements, vitamins, minerals, herbs, and superfoods. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold, VitaScience, and VitaLife brand names. It operates in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, Hong Kong, and China. Vita Life Sciences Limited was founded in 1947 and is headquartered in Melbourne, Australia.

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Phone61 3 9828 0500



Sales & Book Value

Annual Sales$41.44 million
Book ValueA$0.38 per share



Market Cap$38.44 million
Next Earnings DateN/A
OptionableNot Optionable

Receive VLS News and Ratings via Email

Sign-up to receive the latest news and ratings for VLS and its competitors with MarketBeat's FREE daily newsletter.

Vita Life Sciences (ASX:VLS) Frequently Asked Questions

What is Vita Life Sciences' stock symbol?

Vita Life Sciences trades on the ASX under the ticker symbol "VLS."

How often does Vita Life Sciences pay dividends? What is the dividend yield for Vita Life Sciences?

Vita Life Sciences announced a Final dividend on Friday, February 21st. Investors of record on Friday, April 3rd will be paid a dividend of 0.023 per share on Friday, April 3rd. This represents a dividend yield of 3.46%. The ex-dividend date is Thursday, March 19th. View Vita Life Sciences' Dividend History.

Has Vita Life Sciences been receiving favorable news coverage?

Press coverage about VLS stock has been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Vita Life Sciences earned a news sentiment score of -1.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the stock's share price in the near future. View News Stories for Vita Life Sciences.

Who are some of Vita Life Sciences' key competitors?

Who are Vita Life Sciences' key executives?

Vita Life Sciences' management team includes the folowing people:
  • Mr. Andrew O'Keefe, MD & Director
  • Mr. Chin Leng Khoo, CFO & Company Sec.
  • Ms. Melissa Pereira, Head of Marketing
  • Mr. Edward Choop, Chief Exec. Officer of Asia Pacific
  • K. S. Beh, Head of Operations for Asia Pacific

How big of a company is Vita Life Sciences?

Vita Life Sciences has a market capitalization of $0.00 and generates $41.44 million in revenue each year. View Additional Information About Vita Life Sciences.

What is Vita Life Sciences' official website?

The official website for Vita Life Sciences is http://www.vitalifesciences.com/.

How can I contact Vita Life Sciences?

The company can be reached via phone at 61 3 9828 0500.

MarketBeat Community Rating for Vita Life Sciences (ASX VLS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  20 (Vote Outperform)
Underperform Votes:  20 (Vote Underperform)
Total Votes:  40
MarketBeat's community ratings are surveys of what our community members think about Vita Life Sciences and other stocks. Vote "Outperform" if you believe VLS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VLS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Featured Article: What is a Call Option?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel